Veterinary regenerative medicine market was valued at US$ 345.4 million in 2024 and is projected to hit the market valuation of US$ 1,045.9 million by 2033 at a CAGR of 13.1% during the forecast period 2025–2033.
Central nervous system therapeutic market was valued at US$ 129.38 billion in 2024 and is projected to hit the market valuation of US$ 235.87 billion by 2033 at a CAGR of 6.90% during the forecast period 2025–2033.
Saliva collection and diagnostics market was valued at US$ 826.6 million in 2024 and is projected to hit the market valuation of US$ 1,260.5 million by 2033 at a CAGR of 4.8% during the forecast period 2025–2033.
Viral vectors & plasmid DNA manufacturing market was valued at US$ 4.21 billion in 2024 and is projected to hit the market valuation of US$ 20.30 billion by 2033 at a CAGR of 19.1% during the forecast period 2025–2033.
Advanced ophthalmology technology market was valued at US$ 8.78 billion in 2024 and is projected to hit the market valuation of US$ 16.01 billion by 2033 at a CAGR of 6.9% during the forecast period 2025–2033.
Digital health in neurology market was valued at US$ 38.9 billion in 2024 and is projected to hit the market valuation of US$ 229.5 billion by 2033 at a CAGR of 21.8% during the forecast period 2025–2033.